Individualizing induction therapy based on immunological risk is crucial for optimizing outcomes in kidney transplantation.
No takes yet. Share an insight, caveat, or question.
Hod et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: